Present Indian Pharmaceutical Story and Potential Narratives to Enhance Pharmacy Graduates' Career prospects

In India, the drug landscape has changed dramatically in recent years and already has come to the point of being next to the nation's IT business in terms of overall volume and revenue. India is one of the global top six medicine producers.  Vaccines from India are shipped towards more than 150 countries. Approximately 70% of patients take Indian medicines in developing economies.There are reportedly 10,500 production sites in India and thus more than 3,000 drug companies growing at an unprecedented speed.Over 90% of products accepted for Anti-malarial, Antiretroviral & Anti-tubercular have also been approved to India globally.Because of low deployment and operating costs, total costs of manufacturing in India are only about 35-40% of the US. India is among the leading global exporters of generic formulation in terms of quantity.India's drug exports in 2013-14 stood at the US $15 billion.Indian exports are robust and include different pharmaceuticals divisions from APIs to contemporary and ancient Indian drug remedies. Indian drug production makes up approximately one point four percent in value terms of global drug manufacturing and ten percent in terms of output. India is well-positioned to be among the key drivers of healthcare delivery for everyone. Thereby reducing the rather-increasing healthcare expense of industrialized, and developing countries.

There is indeed a clamor in the country for highly skilled pharmaceutical professionals.Numerous pharmacy colleges & institutions mainly deliver pharmacy graduates to meet the pharmaceutical industry's expectations.There are indications, nevertheless, that there is still a considerable difference between the syllabus taught and industry prerequisites.It contributes to a dramatic drop in employment opportunities for Pharma graduates.

Analogously, the task of hospital pharmacists and community pharmacist has expanded and is now not just an individual providing the medication.He is also engaged in educating patients, tracking potential side effects, documenting detrimental drug outcomes as well as plays a crucial role in research into drug discovery.

And so it is imperative to redesign the syllabi for pharmacy courses at all tiers of pharmaceutical education (Diploma, Bachelor, Masters,as well as Doctoral) to train skilled professionals and to strengthen the national health care system.In every transition phase of maximizing pharmaceutical education, consultations are required with all relevant parties, including govt, academia, industrial sector, scientists, graduates, field researchers, and so forth.The review process must be time-framed to frame a workable plan on pharmacy learning.The evaluation framework concepts are:

01. Government reforms for improving the quality of education

02. A categorization of institutions including credentials

03. Incorporating knowledge and skills with curriculum

04. Technology deployment enabled training

05. Attributing pharmacy training towards healthcare and social concerns

06. Adherence to the business sector so pharmacy learning is aligned with career prospects

07. To train the instructors to achieve consistency and quality

08. Instilling professional, and ethical behavior

09. Encouraging innovation and research

10. Subsidizing Pharmacy education

11. Cultivating support structures for pupils